Radiotherapy & Oncology
Volume 81, Issue 2 , Pages 136-142 , November 2006

A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma–Trans Tasman Radiation Oncology Group (TROG) Study 96.06

  • Bryan H. Burmeister

      Affiliations

    • University of Queensland, Melanoma Clinic, Princess Alexandra Hospital, Brisbane, Australia
    • Corresponding Author InformationCorresponding author. Bryan H. Burmeister, University of Queensland, Princess Alexandra Hospital, Woolloongabba 4102, Australia.
  • ,
  • B. Mark Smithers

      Affiliations

    • University of Queensland, Melanoma Clinic, Princess Alexandra Hospital, Brisbane, Australia
  • ,
  • Elizabeth Burmeister

      Affiliations

    • Queensland Cancer Control Analysis Team, Brisbane, Australia
  • ,
  • Kathryn Baumann

      Affiliations

    • Radiation Oncology Mater Centre, Brisbane, Australia
  • ,
  • Sidney Davis

      Affiliations

    • William Buckland Radiotherapy Centre, Melbourne, Australia
  • ,
  • Hedley Krawitz

      Affiliations

    • Auckland Hospital, Auckland, New Zealand
  • ,
  • Carol Johnson

      Affiliations

    • Wellington Hospital, Wellington, New Zealand
  • ,
  • Nigel Spry

      Affiliations

    • Sir Charles Gairdner Hospital, Perth, Australia

Received 24 May 2006 ,Revised 25 September 2006 ,Accepted 2 October 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The study was conducted as a multi-centre trial under the auspices of the Trans Tasman Radiation Oncology Group (TROG).

PII: S0167-8140(06)00529-9

doi: 10.1016/j.radonc.2006.10.001

Radiotherapy & Oncology
Volume 81, Issue 2 , Pages 136-142 , November 2006